- Home
- MIRM vs SSRM Comparison
MIRM vs SSRM Comparison
Compare MIRM & SSRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | SSRM |
|---|---|---|
| Founded | 2018 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.5B |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | MIRM | SSRM |
|---|---|---|
| Price | $93.42 | $36.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $119.85 | $32.74 |
| AVG Volume (30 Days) | 456.7K | ★ 2.3M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 74.59 | ★ 243.41 |
| EPS | N/A | ★ N/A |
| Revenue | $19,138,000.00 | ★ $1,629,637,000.00 |
| Revenue This Year | $26.22 | $56.48 |
| Revenue Next Year | $22.04 | $4.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 63.68 |
| 52 Week Low | $63.23 | $18.19 |
| 52 Week High | $130.00 | $39.44 |
Technical Indicators
Market Signals| Indicator | MIRM | SSRM |
|---|---|---|
| Relative Strength Index (RSI) | 38.75 | 54.15 |
| Support Level | $88.08 | $35.69 |
| Resistance Level | $98.03 | $36.40 |
| Average True Range (ATR) | 3.82 | 1.19 |
| MACD | -0.03 | -0.48 |
| Stochastic Oscillator | 1.32 | 37.81 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.